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 ABSTRACT 
Ehrlichia chaffeensis, a Gram-negative organism belonging to the order 
Rickettsiales, is responsible for an emerging infectious disease in humans, the 
human monocytic ehrlichiosis. E. chaffeensis also infects several other vertebrate 
hosts including dogs, goats, coyotes and white tailed deers. This organism is 
transmitted by an infected tick, Amblyomma americanum. The exact pathogenic 
mechanisms involved for the persistence of the pathogen in vertebrate hosts are still 
unclear. E. chaffeensis protein expression varies significantly in vertebrate and tick 
hosts. Differentially expressed proteins include the immunodominant outer 
membrane proteins encoded by the p28-Omp multigene locus. The p28-Omp 14 is 
expressed primarily in tick cells and the p28-Omp 19 is the major expressed protein 
in macrophages both under in vitro and in vivo conditions. The objective of this study 
is to prepare recombinant proteins and use them to assess the secondary structures 
and protein functions. The protein sequences were analyzed with the aid of 
bioinformatics programs to make structural predictions. The analysis suggested the 
presence of eight β barrel structures for both the p28-Omp proteins. The coding 
sequence of the p28-Omp genes were cloned and over expressions of proteins in 
in E. coli was accomplished by using the plasmid expression construct, pET28. The 
proteins were purified to near homogeneity and used to refold using detergents to 
mimic native protein structure in the bacterial outer membrane. Refolding of proteins 
was analyzed by two methods; SDS-PAGE and Circular Dichroism. The Circular 
dichroism spectroscopy analysis suggested the formation of β-sheet structures of 
proteins in micelles formed with the detergents. β-sheet structures may have been 
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formed with the hydrophobic domains of the protein imbedded in the micelles. The 
hydrophilic segments (predicted by bio informatics analysis) may be exposed to the 
aqueous phase. The recombinant proteins were also used to prepare 
proteoliposomes and tested for the porin activity.  The analysis demonstrated the 
porin activity for both p28-Omp 14 and 19 recombinant proteins by using mono-, di- 
and tetra- saccharides as well as for amino acid L-glutamine. This study forms the 
basis for initiating studies to compare the structural difference between the two 
differentially expressed proteins of E. chaffeensis. 
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ABSTRACT 
Ehrlichia chaffeensis, a Gram-negative organism belonging to the order 
Rickettsiales, is responsible for an emerging infectious disease in humans, the 
human monocytic ehrlichiosis. E. chaffeensis also infects several other vertebrate 
hosts including dogs, goats, coyotes and white tailed deers. This organism is 
transmitted by an infected tick, Amblyomma americanum. The exact pathogenic 
mechanisms involved for the persistence of the pathogen in vertebrate hosts are still 
unclear. E. chaffeensis protein expression varies significantly in vertebrate and tick 
hosts. Differentially expressed proteins include the immunodominant outer 
membrane proteins encoded by the p28-Omp multigene locus. The p28-Omp 14 is 
expressed primarily in tick cells and the p28-Omp 19 is the major expressed protein 
in macrophages both under in vitro and in vivo conditions. The objective of this study 
is to prepare recombinant proteins and use them to assess the secondary structures 
and protein functions. The protein sequences were analyzed with the aid of 
bioinformatics programs to make structural predictions. The analysis suggested the 
presence of eight β barrel structures for both the p28-Omp proteins. The coding 
sequence of the p28-Omp genes were cloned and over expressions of proteins in 
in E. coli was accomplished by using the plasmid expression construct, pET28. The 
proteins were purified to near homogeneity and used to refold using detergents to 
mimic native protein structure in the bacterial outer membrane. Refolding of proteins 
was analyzed by two methods; SDS-PAGE and Circular Dichroism. The Circular 
dichroism spectroscopy analysis suggested the formation of β-sheet structures of 
proteins in micelles formed with the detergents. β-sheet structures may have been 
formed with the hydrophobic domains of the protein imbedded in the micelles. The 
hydrophilic segments (predicted by bio informatics analysis) may be exposed to the 
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aqueous phase. The recombinant proteins were also used to prepare 
proteoliposomes and tested for the porin activity.  The analysis demonstrated the 
porin activity for both p28-Omp 14 and 19 recombinant proteins by using mono-, di- 
and tetra- saccharides as well as for amino acid L-glutamine. This study forms the 
basis for initiating studies to compare the structural difference between the two 
differentially expressed proteins of E. chaffeensis. 
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Introduction  
Vector borne diseases  
Three major factors contribute to the spread of vector-borne diseases; 
infectious microorganisms (eg: viruses, bacteria, parasites), vectors (eg: 
mosquitoes, ticks, fleas) and reservoir hosts [1, 2]. Vectors-borne disease agents are 
mostly transmitted by arthropod vectors. Vectors act as vehicles by which infectious 
agents are transmitted from an infected host to another susceptible host [2]. Major 
vector-borne infectious agents are maintained in nature by persisting in reservoir 
hosts and arthropod vectors [3, 4]. Some of the important infectious diseases in 
humans are the result of infections caused by vectors such as mosquitoes and ticks 
[5, 6]. For example, malaria is caused by a mosquito-borne infection with 
Plasmodium species. Human malaria is still considered the most important disease 
because it is responsible for significant morbidity and mortality [7]. Nearly 350-400 
million human cases of malaria are reported annually caused by Plasmodium 
falciparum and Plasmodium vivax [8]. About half a million of these result in fatalities 
[8-11]. Similarly, tick-borne diseases are a significant health concern to humans and 
domestic animals [2, 3]. For example, the Lyme disease is a major problem for 
humans and various vertebrate animals. It has a widespread distribution throughout 
the world. It is discovered in 1975 as a human disease and is responsible for 1000s 
of human cases in the USA each year [12, 13]. Louse-borne epidemic typhus, 
caused by Rickettsia prowozakii, is another vector-borne disease responsible for 
significant fatalities in people [14, 15]. Among populations concentrated at places 
such as concentration camps during wars or civil disturbances, R. prowozakii 
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infections prevail and cause significant mortality (up to 30%). For example, deaths 
resulting from this disease are often more in wars than war casualties. For example 
in 1997 at refugee camps in Burundi, Africa, nearly 30,000 people died due to R. 
prowozakii infections [6, 16].  
Rocky Mountain spotted fever, African sleeping sickness, sandfly fever, 
Chages disease, and louse borne typhus are among the vector borne disease 
indentified in early 1900s [5]. From 1984 to 2004, nine new tick borne diseases 
caused by rickettsial agents have been reported [17]. Human Ehrlichiosis and 
Anaplasmosis are among the rickettsial diseases, discovered during the last three 
decades [17-21] 
Vector-borne diseases also have a high an impact on the economy of the 
world due to the diseases caused to agriculture animals. Every year, millions of 
dollars of economic losses occur in the world as a result of the vector-borne 
diseases [22, 23]. For example, outbreak of babesiosis and anaplasmosis in the early 
1990s in Latin America reported an estimated annual economic loss between 875 to 
1,365 million dollars [24]. 
 
Tick borne diseases 
Ticks are the second major vectors after mosquitoes for spreading infectious 
diseases to animals and people [25-27]. Ticks are blood sucking parasitic arthropods 
(obligate, hematophagous) and are found in every region of the world [5, 28]. Ancient 
Greeks mentioned about ticks, but an actual demonstration of ticks as the pathogen 
transmitting vectors is not reported until the 19th century where Smith and Kilbourne 
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demonstrated the Babesia bigemina, a protozoan parasite transmission by 
Boophilus ticks to cattle [29, 30]. Ticks act as vectors for transmitting various 
infectious agents including protozoans, bacteria and viruses. For example, 
protozoan parasite Cytauxzoonosis felis is transmitted by Dermocentar variabilis to 
cats in South and Southeast regions of the U.S.A [31]. This parasite has a wide 
spread prevalence in sub Saharan Africa and is transmitted by ticks to various 
felidea species [31, 32]. Babesia microti is another protozoan parasite transmitted by 
ticks (Ixodes scapularis) and causes infections in humans [33]. Similarly, several 
Babesia species transmitted by ticks are responsible for babosiosis in cattle, horses, 
and dogs. Rickettsial bacteria, Ehrlichia chaffeensis, Ehrlichia ewingii, and 
Anaplasma phagocytophilum are transmitted by Ixodid ticks and cause Ehrlichiosis 
and Anaplasmaosis, respectively in people and in domestic animals [34-37]. Borrelia 
burgdorferi (another bacterial pathogen), transmitted by Ixodes species, is 
responsible for the Lyme disease in people and vertebrate animals [13]. Rocky 
Mountain spotted fever agent (Rickettsia rickettsii) is transmitted by three different 
species of ticks (Dermacentor variabilis, Dermacentor andersoni and Amblyomma 
cajennense) and is a major health problem in people and dogs around the world, 
including the U.S.A [27, 38, 39]. An example for tick-borne viral infection is Colorado 
tick fever caused by Colorado tick fever virus transmitted by D. andersoni ticks to 
humans [40]. 
Ticks belong to the class Arachnida. There are three tick families: Ixodidae 
(hard ticks), Argasidae (soft ticks) and Nuttalliellidae (morphologically intermediate 
between hard and soft ticks). The hard tick family has a list of 694 identified species, 
whereas the soft tick family has 177 recognized species and Nuttalliellidae family 
included only one species [5, 41, 42]. Larva, nymph or adult ticks can acquire a 
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pathogen from an infected host during their blood feeding. Pathogens acquired in 
larval or nymphal stages progress to nymphal or adult stages, respectively [28, 43]. 
Pathogens may then be transmitted to a niave host during subsequent blood feeding 
cycles [5]. Some disease causing agents may be transovarially passed on from an 
adult female to larvae via infected eggs, while other disease causing agents are 
maintained only transtadially (from larva to nymphs and nymph to adult). For 
example, Rickettsia species are transovarially maintained while Ehrlichia and 
Anaplasma species are only maintained transtadially [44]. Generally, ticks have three 
host life cycles. Ticks seek a host for attachment to feed for several days. Once 
replete, ticks detach from a host and use the blood meal to progress to its next stage 
of life cycle. The life cycle of Ixodid ticks is typically completed in 2-3 years, which 
depends on the environment and the availability of hosts. Importantly, ticks quest for 
a host when seeking a blood meal and may wait in the environment for a long period 
until a suitable host is found [5, 42]. Humans are accidental hosts for tick feeding and 
pathogen transmission. Few species of ticks are host-specific for seeking a blood 
meal, whereas most others can take a blood meal from a wide range of vertebrates 
[5]. 
Ticks serve as the major vectors for rickettsial pathogens belonging to the 
rickettsiaceae and anaplasmatace family organisms. Ixodid ticks are first considered 
as the vectors for rickettsial organisms when Rocky Mountain wood tick 
(Dermacentor andersoni) is identified as the vector for transmitting Rickettsia 
rickettsii, the agent of Rocky Mountain spotted fever in the U.S.A in 1906 [45]. Ticks 
are responsible for causing several important rickettsials diseases to people. They 
include Rocky Mountain spotted fever (Western hemisphere), Rickettsial pox (USA 
and former Soviet Union), Boutonneuse fever (Mediterranean countries, Africa, 
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Southwest Asia and India), Siberian tick typhus (Siberia, Mongolia, northern China), 
Australian tick typhus (Australia), Oriental spotted fever (Japan), and African tick-bite 
fever (South Africa) [45-47]. Tick-borne rickettsial diseases in people caused by 
Anaplasmataceae family pathogens include human granulocytic anaplasmosis, 
human ewingii ehrlichiosis, and human monocytic ehrlichiosis [35, 48-50]. Ticks are 
also the major vectors for the Anaplasmataceae family pathogen diseases in various 
vertebrates including dogs, cattles and sheeps [37, 50, 51]. A list of 
Anaplasmataceae tick-borne human and animal infections disease is presented in 
Table 1.1. 
 
Classification 
Members of the genera Ehrlichia and Anaplasma are obligate intracellular 
bacteria currently placed in the proteobacteria phylum, secition alpha; order 
Rickettsials and family Anaplasmataceae, while other closely related genera are 
Rickettsia and Orientia belonging to the Rickettsiacae family within the order 
Rickettsials [52, 53]. 
The Anaplasmataceae family includes four genera, Anaplasama, Ehrlichia, 
Wolbachia and Neorickettsia [52][54]. Anaplasama and Ehrlichia species are 
transmitted by ticks [37, 52]. Neorecketisia species are also vector-borne pathogens, 
but are harbored by trematodes [52]. Wolbachia species are non-pathogenic 
endosymbionts in various arthropods and nematodes [55, 56]. Anaplasma genus 
includes several identified pathogens of people and animals: A. phagocytophilum, A. 
mrginale, A. centrala, A. ovis and Anaplasma platys [52]. Similarly, Ehrlichia genus 
also includes several pathogens causing diseases in people and animals. They 
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include E. chaffeensis, E. ewingii, E. canis, E. muris and E. ruminantium [19, 48, 50, 
52]. Neorickettsia species included N. sennestsu (human pathogen), N.risticii (horse 
pathogen), and N. helmentheca (canine pathogen) [57, 58]. 
Ehrlichia species infect predominantly leukocytes of vertebrate hosts. The 
only exception is E. ruminantium that infects endothelial cells. Anaplasma species 
infect bone marrow derived cells in different animal hosts including leukocytes, 
erythrocytes, and platelets. Neorickettsia species infect predominantly mononuclear 
phagocytes and occasionally enterocytes in the mammalian hosts [54]. 
E. chaffeensis is an emerging human infectious agent which causes human 
monocytotropic ehrlichiosis (HME) [49, 59, 60]. E. chaffeensis is first discovered in 
1986 in Arkansas in a human patient with flu like clinical symptoms [59]. Peripheral 
blood smears analysis of the patient lead to the identification of E. canis like 
organism [61]. The identity of the organism causing the disease is established in 
1991 following the molecular genetics analysis [61]. The organism is closely related 
to E. cains, and is named as E. chaffeensis [49]. Subsequent studies resulted in 
culturing the organism recovered from a patient in canine macrophage cell line, 
DH82. 
           E. chaffeensis is transmitted by the lone star tick, Amblyomma americanum. 
This bacterium is maintained in nature primarily in white-tailed deer (Odocoileus 
virginianus) population and in lone-star ticks [25, 62-64] . A. americanum ticks feed 
on white-tailed deer, and thus provide an ample opportunity for E. chaffeensis to be 
acquired and transmitted between ticks and deer population (Figure 1 and 2). E. 
chaffeensis also infects other vertebrates including, dogs, goats, rodents and mule 
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deer [20, 65-68]. White tailed deer is considered the primary reservoir host for the 
transmission cycle of this organism [64]. 
Reports of HME cases have increased during the last three decades. The 
higher incidence of HME is reported in immune compromised and elderly people, 
particularly with high morbidity and mortality rates [60]. An average number of 600 
human cases of HME are reported each year in the United States (Figure 3) [60, 69]. 
Most of the reported HME cases are from south central and southeastern regions of 
the United States where the vector tick population is more prevalent [60, 70-
73](Figure 4). 
E. chaffeensis is an obligate parasitic pathogen that infects and multiplies 
within monocytes and macrophages of blood and various organs, including spleen, 
liver, lung and bone marrow of a host [19, 74, 75]. This pathogen also infects 
lymphocytes, atypical lymphocytes; promyelocytes, metamyelocytes, and in 
segmented neutrophils, but major infected cells are monocytes and macrophages 
[19, 76]. 
E. chaffeensis grows within the cytoplasmic vacuoles derived from the 
formation of early endosomes. Light microscopic examination of the polychromatic 
stained infected cells reveal E. chaffeensis organisms as mulberry-like structures 
within intracytoplasmic inclusions [77]. The organisms replicating within the 
cytoplasmic vacuoles are commonly referred to as morula. E. chaffeensis replicates 
within the vacuoles by binary fission [78]. Electron microscopic examination reveals 
two morphological forms; the dense core bodies (DCs) and reticulate bodies (RCs). 
Dense core bodies are electron dense bodies, considered as the metabolically 
inactive forms (Figure 6). The DCs are infectious forms released from infected cells 
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by lysis or by exocytosis. The RCs are metabolically active replicating forms mostly 
seen within the phagosomes. 
 
Clinical signs 
The clinical signs of E. chaffeensis infection causing HME disease may 
appear in patients within one to two weeks following blood feeding by an infected A. 
americanum tick and the pathogen transmission [79]. The early clinical signs vary 
from asymptomatic to mild flu-like symptoms [60, 79]. Most common symptoms 
include malaise, headache, lower back pain, muscle aches, chills, nausea, 
gastrointestinal symptoms, and development of sudden onset fever ~102˚F [80, 81]. 
Sometimes, the symptoms may include cough, pharyngitis, swollen lymph nodes, 
and vomiting [73, 82]. Some patients also develop rashes (30-40%).  The infection 
may progress to severe illness with multiorgans failure. Greater than 50% patients 
are reported to exhibit moderate leucopenia and a sharp decrease in the white blood 
cell count [73, 82]. Nearly 90% of patients reported a decrease in the number of 
platelets. Along with abnormalities in the blood, elevated levels of liver transaminase 
are often noted because of infection [80, 81]. Approximately 20% of infected patients 
develop signs and symptoms of central nervous system of meningitis syndrome [49]. 
Although people of all age groups are susceptible, but most severe cases are 
observed in elderly age people with compromised immunity. The fatality of an 
individual may occur due to hemorrhage, organ failure, or development of secondary 
bacterial infections [49, 83].  
Diagnosis for E. chaffeensis infection is more often based on patient’s history 
(such as exposure to tick bites) [60], a blood smear analysis revealing the presence 
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of infected monocytes with other laboratory techniques, such as the indirect 
immunofluroscence assay  for E. chaffeensis antibodies and PCR amplification of a 
specific genomic region of the pathogen. Studying blood smears is a common 
diagnosing practice, but it is considered as insensitive in detecting the pathogen. 
The pathogen is identified by staining blood smears by Romanovsky type 
polychromatic stains [84]. Indirect immunoflorscence assay (IFA) is used for the 
detection of antibodies against E. chaffeensis antigens, but due to cross reactivity 
with other closely related organisms, the test can lead to false positives [85]. In 
patients at early stages of infection, the low amount of antibodies may result in false 
negatives. PCR assays are used for identifying DNA recovered from a whole blood 
sample or a serum sample. The PCR assays are rapid, sensitive, and specific in 
diagnosing a patient sample, but are not routinely used for human clinical diagnosis. 
The targets used for PCR assays include GroESL gene, Variable Length PCR 
Target gene (VLPT) or species-specific segment of a 16S rRNA gene [60, 61, 80, 86, 
87]. 
 
Treatment 
E. chaffeensis appears to be resistant to most of the antibiotics, including 
ciprofloxacin and penicillin. Tetracycline and its derivatives, broad-spectrum 
antimicrobials which inhibit protein synthesis in various bacterial species have 
proven very effective in treating the infection. Doxycycline in particular is considered 
as an effective drug of choice for the HME cases [19, 79]. 
 
13 
 
Molecular biology: 
 The genome of E. chaffeensis is 1.18 mb and includes 1115 open reading 
frames [88, 89]. The E. chaffeensis genome is considerably smaller than E. coli 
genome. It is about one quarter in size when compared to E. coli genome. Many 
genes in E. chaffeensis have been lost in the course of evolution, possibly for its 
adaptation to obligate parasitic life [89]. They include genes required for the 
biosynthesis of lipopolysaccharides and peptidoglycans [90, 91]. This organism is an 
auxotroph and depends on the host for amino acids and other metabolites. 
Several studies reported the molecular characterization of various genes in 
this organism. They include various unnamed genes for p19, p22, p28, p32, p44, 
p106, p120, p200 kDa protein coding genes and quinolate synthatase gene [91-94]. 
In addition, Type VI secretin system and two components regulator protein system 
also have been partially characterized [95, 96]. 
Several immune reactive proteins of E. chaffeensis were identified from this 
organism. They include, p28 kDa, p47 kDa, p120 kDa proteins are expressed on the 
outer membrane of E. chaffeensis and appear to interact with the host cells [77, 92]. 
The p120 kDa and p47 kDa proteins are differentially expressed in dense core 
bodies in infected monocytes, while the p28 proteins are shown to be expressed 
differentially in the tick cells and macrophages [77, 85]. Several genes of E. 
chaffeensis reported in literature contain tandem repeat sequence within the protein 
coding sequences. They are p32 (previously known as variable length PCR tandem 
repeat), p47, and p120 and p200. The tandem repeat sequences include amino 
acids serine and threonine. These tandem repeat sequences of proteins are strongly 
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recognized by the immune sera of E. chaffeensis infected hosts, including humans 
and dogs [85, 97, 98] . 
The p47 is 285 amino acids longer, immunoreactive protein and includes 19 
amino acids tandem repeats. Approximately half of the protein is represented by the 
repeated sequences [98]. The p47 protein shows homology with renin 
receptor/ATP6AP2/CAPER protein and with DNA III polymerase subunit gamma. 
These proteins were expressed only on the surface of the dense core forms of E 
chaffeensis [98, 99].  
The p120 kDa protein is another immunoreactive differentially expressed 
protein of this organism [97]. Its expression is higher in the dense core bodies. This 
protein is also composed of multiple repeat sequences, which includes serine 
residues. This protein may act as an adhesion and interacts with the host cell to 
facilitate pathogen survival [87]. The immunogenic p140 kDa protein of E. canis is 
homologues to p120 kDa protein of E chaffeensis [87, 97]. 
The p200-kDa protein, previously considered as glycoprotein, is also a 
tandem repeat protein. The tandem repeats in this protein are 19 ankyrin sequences 
[98]. This protein is similar to p200 and AnKA of E. canis and A. phagocytophilum, 
respectively [100]. (Which also contain ankyrine repeats). These proteins are 
translocated into the nuclei of infected host cells. They interact with the adenine –
rich motif of host gene promoters and intergenic Alu repeat sequence [98, 101]. The 
p200-kDa protein may also play a role in inhibiting apoptosis of the infected cells. 
The implications of these properties are that the bacterium may alter the host gene 
expression in support of its survival [101].  
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The p28 proteins are the major expressed proteins on the outer membrane of 
the organism [102-105]. The homologues of these proteins are identified in other 
Ehrlichia species, Such as E. rumantium, E. muris, E. canis [103, 104]. These 
proteins also share considerable homology to other surface proteins of A. 
phagocytophilum and A. marginala. A. phagocytophilum and A. marginala proteins 
have been shown to be involved in antigenic variation in support of the pathogen to 
escape from host immunity [106-110]. The p28 proteins in E. chaffeensis are 
differentially expressed in macrophages of vertebrate hosts and infected tick cells 
under both in vitro and in vivo conditions [111-115]. The differentially expressed p28 
proteins in macrophages and tick cells are p28-Omp14 and 19, respectively [112-
114]. 
Several other proteins are also expressed in the intercellular development of 
the pathogen during its replication and maturation. They include type four secretin 
system (T4SS) apparatus proteins and two-component regulator system proteins. 
The T4SS is an ATP dependent bacterial transport system which transports 
macromolecules (such as proteins and DNA) across the bacterial and host cell 
membrane [95, 116]. The T4SS may be used by Gram negative bacteria to deliver 
virulence factors to modulate the host genomes in support of their survival. The 
T4SS proteins expression is observed in the organism present in infected host cells. 
The T4SS proteins are constitute of a complex assembly of proteins. They include 
proteins made from four virB2, one virB3, two virB4, four virB6, two virB8, two virB9, 
one virB10, one virB11and one virD4 [95, 117].  
Recent studies suggest that T4SS is used to deliver AnkA repeat proteins 
from E. chaffeensis and A. phagocytophilum to infected host cells [95, 118, 119]. The 
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AnkA a protein of A. phagocytophilum has also been shown to be transported into 
host cell nucleus and interact with promoters and various repeat sequences in the 
genome. The significance of these interactions remains to be established [118-120]. 
However, like other Gram-negative bacteria, the proteins secreted by T4SS may be 
important in altering the host gene expression in support of the pathogen for its 
survival. 
E. chaffeensis genome includes genes required for the expression of two 
component regulatory system [121, 122]. Recent studies demonstrate that three 
histidine kinase proteins and three response regulators are expressed by E. 
chaffeesnsis when it replicates in human leucocytes [121]. Furthermore, inhibition of 
the histidine kinase function by the drug closantel (a known inhibitor of histidine 
kinase) resulted in the complete blocking of infection with this organism to host cells. 
These results suggest that the two component regulatory system is needed for the 
pathogen’s survival in vertebrate host cells [54, 116]. The two component regulatory 
system is also functional in the A. pahagocytophilum [89]. 
E. chaffeensis obtains cholesterol or related sterols form the hosts or its 
environment to stabilize the cytoplasm membrane as it lacks genes for the 
synthesizing sterols. E. chaffeensis also lacks genes for synthesizing 
lipopolysaccharides (LPS) [90, 123]. In the absence of LPS on the cell surface, the 
organism is only protected with the membrane containing cholesterols [90, 124].  
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The host response to the E. chaffeensis infection 
More severe cases caused by E. chaffeensis are reported in immune 
compromised individuals and elderly people. In recent times, severe cases of HME 
are also reported in children [60, 125, 126]. Several studies have been carried out to 
understand the immune response by host during infection with E. chaffeensis by 
performing experimental infections using the murine host. The murine studies 
suggest that the immunocompentent mice are able to clear the infection within 10-14 
days [127-129]. In severe combined immune deficient (SCID) mice, which lack B and 
T-cells, the pathogen causes severe fatal disease [130, 131]. Persistence infection is 
observed in MHC II deficient mice infected with E. chaffeensis [129]. CD4+ helper T-
cells deficient in mice clears the infection, but the clearance is delayed. The delayed 
clearance in CD4+ T-cell in different mice suggests that in amongst these T-cells, 
alternate T-cells such as gamma, delta T-cells may contribute to the pathogen 
clearance [132]. Similarly, infection in toll receptor deficient mice results in delaying 
the clearance of the pathogen for up to 30 days [127, 132]. These observations 
suggest the importance of both B-cells and T-cells in clearing the infection by host. 
These studies also demonstrate the importance of MHC II and toll like receptors to 
generate immunity against E. chaffeensis infections [127]. 
Antibodies also play an important role in the clearance of the pathogen from a 
host. It has been reported that the immune serum from an infected immune 
competent mice can protect E. chaffeensis infected SCID mice [129, 133]. The 
immunsera includes antibodies which recognize proteins expressed on outer 
membrane of E. chaffeensis [133, 134]. The antibody assessment studies also 
demonstrate that the antibodies alone are not sufficient to clear the pathogen from 
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the infected host. Cytokines are also involved in clearing of the pathogen [135]. 
Cytokines have an important role in mediating E. chaffeensis clearance from a 
vertebrate host. Human monocytic cell line (THP I) infected with E. chaffeensis 
suppresses the expression of several cytokines including IL-1α, IL-4, IL-6, IL-12, IL-
15, and IL-18 [135]. Cytokines IL 15 and IL18 usually serve as the activators of IFN 
which activates the macrophage cells to kill a pathogen [54, 135, 136].  
Recent proteomic studies from our laboratory identified 278 expressed 
proteins of E. chaffeensis [137]. The expressed proteins included numerous 
differentially expressed proteins of the organism grown in macrophages and tick 
cells [138]. The differentially expressed proteins also included several outer 
membrane proteins. Our laboratory also reported differences in the host response 
against E. chaffeensis originating from tick cells and macrophages in the murine 
host. These studies suggest that the pathogen clearance is delayed in vertebrate 
host when E. chaffeensis originated from tick cells [132]. The antibody and cytokine 
responses in mice infected with tick cell derived bacteria differed considerably 
compared to mice infected with organisms originating from vertebrate macrophages. 
The antibody response also steadily increased in mice infected with tick cell derived 
bacteria [128, 139]. Together these data suggest that the host cell specific differential 
protein expression by E. chaffeensis aids in the pathogens adaptation and 
persistence in a vertebrate host. As differentially expressed proteins included p28-
Omp multigene locus proteins (described details below), the secondary structure 
analysis (conducted in the current studies) will be important to assess the biological 
significance of these proteins to the pathogen. 
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p28- Outer membrane proteins (p28-Omps) 
p28-Omps of E. chaffeensis are encoded by a multigene locus (p28-Omp 
locus). This multigene locus contains 22 tandemly arranged paralogos genes which 
are separated by intergenic sequence varying from 9 to 600 bp [88, 111, 113, 115, 
137, 139-141]. As the estimated molecular weight of the proteins encoded from p28 
locus is between 28 to 32 kDa, the genes are referred to as p28-Omps. The p28-
Omp gene coding sequences share extensive homology, throughout the coding 
sequences, except for three hypervariable regions [140]. The hypervariable regions 
contain immunogenic B-cell epitopes and are recognized by sera from the E. 
chaffeensis infected people and animals [134, 142]. The p28-Omp locus also differs 
considerably in several E. chaffeensis isolates [115].  
The homologs of p28-Omp locus are also found in other Ehrlichia species. 
The p28-Omp locus (referred as p30-Omp locus) in E. canis also includes 22 
tandemly arranged genes. In E. ruminantium, this locus is referred as MAP1 and it 
includes 19 genes [143]. E. ewingii and E. muris has 16 and 21 paralogous genes, 
respectively [104, 105]. (A cartoon representation of the p28-Omp multigene locus 
including the host specifically expressed genes of E. chaffeensis, E. canis, E. 
ruminantum is shown in Figure 7) 
Several studies have been performed to map gene expression of the p28-
Omp loci in Ehrlichia species. Based on the transcriptional analysis, multiple genes 
of the p28-Omp locus in E. chaffeensis are shown to be transcriptionally active in 
macrophages with maximum expression observed for p28-Omp 19 [105, 141, 143, 
144]. In tick cells, p28 Omp 14 gene product is the only one detected. The 
differential expression is conformed in infected vertebrate hosts and ticks [104, 112, 
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145-147]. The differential expression is also reported for homologs of the p28-Omp 
multigene loci E. canis and E. rumianatium. These differentially expressed proteins 
of E. chaffeensis and E. canis are also post transnationally modified to include 
glycosylation and phosphorylation moieties [138, 141]. The major surface protein 
(msp2) and outer membrane protein (p44) of A. marginale and A. phagocytophilum, 
respectively, are closely related to p28-Omp proteins [106-110]. The msp2 and p44 
proteins are also made from multigene loci and include highly immunogenic variable 
regions [52, 145]. The antigenic variants generated from msp 2 and p44 genes of A. 
marginala and A. phagocytophilum are shown to play a role in immune evasion [51, 
148-150].  
Despite the detailed knowledge about the p28-Omp genes primary structure, 
their expression patterns, their recognitions by B-cells, very little is known about their 
secondary and tertiary structure in the outer membrane, similarly, their biological 
function is not well described. In an effort to understand the structure and functional 
relations, kumagai et al performed structure predication analysis and also examined 
the porin activity for two p28-Omp 18 and 19 proteins.  The studies also suggest that 
two of the p28-Omp protein 18 and Omp 19 possess porin activity [151].  
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Figures related to Chapter one  
                                                   
Figure 1 Amblyomma Americanum                            Figure 2 White tailed deer  
 
 
 
 
 
Source: http://www.cdc.gov/Ncidod/dvrd/ehrlichia/Natural_Hx/nathx1.htm  
   Figure 3 Proposed life cycles for E. chaffeensis. 
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Figure 4 Number of Ehrlichiosis cases (caused by Ehrlichia chaffeensis) 
reported to CDC by state health departments, 1999-2006.  
(Source: CDC National Electronic Telecommunications System for 
Surveillance (NETSS) data). 
 
                           
Figure 5 Distribution of Ambloymma Americanum USA. 
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 Figure 6 Transmission electron microscopy analysis was performed on E. 
chaffeensis-infected macrophages (A) and tick cells (ISE6) (B). (N, nucleus; DC, 
dense-cored bodies of Ehrlichia in phagosomes; RC, reticulate bodies of Ehrlichia in 
phagosome) (Reproduced with permission from Frontiers In Biosciences. 14: 3259-
73). 
 
 
 
 
 
 
 
24 
 
 
 
Figure 7 A cartoon representing the p28-Omp loci of E. chaffeensis, E. canis 
and E. ruminantium with identified expressed proteins from the p28-Omp genes in 
vertebrate macrophages (hatched boxes) and tick cells (checker board boxes) are 
presented (Reproduced with permission from Frontiers In Biosciences. 14: 3259-73). 
 
  
Figure 8 Northern blot analysis: DH82 (lanes 1 and 2) and tick cell line, ISE6 
(lanes 3 and 4) assessed by Northern blot analysis using p28-Omp 14 or 19 gene-
specific 32P-labeled probes. Gene 19 transcript of the size 0.9 kb is detected only 
in macrophage-derived RNA. Similarly, the tick cell-derived RNA contained 0.9 kb 
transcript for gene 
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CHAPTER II:-  
STRUCURAL PREDICTION ANALYSIS OF EHRLICHIA CHAFFEENSIS 
OUTER MEMBRANE PROTEINS, P28 OMP-14 AND P28 OMP-19 ASSESSED BY 
CIRCULAR DICHROSIM AND PORIM ASSAY 
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Introduction 
Ehrlichia chaffeensis, obligate intercellular bacterium, causes human 
monocytic ehrlichiosis (HME) [49, 61]. HME is considered as an emerging disease in 
people. E. chaffeensis resides in phaogosomes of monocytes or macrophages of 
vertebrate hosts [61]. This organism also infects several other vertebrates including 
dog, goat, coyote, and white tailed deer [20, 65-68]. Amblyomma americanum tick 
serves as the vector and white tailed deer serves as the reservoir host for this 
pathogen [62-64, 152]. 
E. chaffeensis may have evolved unique protein expression strategies in 
support of its growth in tick and vertebrate host environments. This organism 
persists in both vertebrate and tick hosts. Recent studies demonstrated changes in 
the protein expression of the organism replicating in macrophages and tick cells 
[143]. Host cell-specific differential protein expression may be essential for E. 
chaffeensis to adapt to vertebrate and tick hosts [112, 137, 138, 141]. Differentially 
expressed proteins of E. chaffeensis include several outer membrane proteins. The 
p28 Omp proteins are the most abundant outer membrane proteins expressed by E. 
chaffeensis [112, 141, 143]. 
In tick cells and macrophages, the p28-Omp proteins are differentially 
expressed. P28-Omp14 is the expressed protein in tick cells while p28-Omp19 is the 
major expressed protein in macrophages [128, 138]. The differential expression of 
these proteins is also confirmed for the pathogen in tick and vertebrate hosts [112, 
137, 138, 141]. 
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The p28 Omp proteins consist of three hyper variable regions are which 
contain hydrophilic domains and are recognized by the immune sera against E. 
chaffeensis [139, 140, 146]. Immunization with the p28-Omp recombinant proteins 
protects SCID mice against of E. chaffeensis infections [134, 142]. 
Typically, the outer membrane proteins serve as the permeability barriers to 
excrete noxious substances of bacteria and for the uptake of nutrients from the 
environment [153]. The precise functions of the p28-Omps in E. chaffeensis remain 
to be established.  
In this study, we expressed the p28-Omp14 and p28-Omp 19 gene products 
of E. chaffeensis using E. coli expression system. The recombinant proteins were 
purified to near homogeneity and used to study the refolding in detergents to mimic 
structures in the outer membrane of the organism. The protein function of p28-Omp 
14 and 19 was assessed by evaluating the porin activity after reconstituting the 
protein in a liposome. 
 
Materials and method 
In silco analysis:   
We analyzed the protein sequences of p28-Omp 14 and 19 to predict the 
hydrophobicity using the ProtoScale program available at 
(http://expasy.org/tools/protscale.html). By calculating the average hydrophobicity 
and average amphilicity index, can structural predications can be made for a protein. 
The hydropathy plot is calculated with the help of index of Kyte and Doolittle and 
amphiphilicity indexes [154, 155]. The amphilphilicity of polar side chains is the 
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second parameter with a calculated index of amino acid charges. The transfer 
energy of the hydrocarbon part of a polar side chains are also used by the program 
to prepare the hydrophobicity plot [154].  
Analysis of the two dimensional structures of the p28-Omp 14 and 19 was done with 
the help of the PRED-TMBB protein prediction program [155, 156] 
(http://biophysics.biol.uoa.gr/PRED-TMBB/). CPHmodels-3.0 Program is helpful in the 
predicting the 3D MODEL of the protein (http://www.cbs.dtu.dk/services/CPHmodels/) 
[157]. This program is useful in predicting a 3D structure of a protein. The 3D model 
predictions for p28 Omp-14 and 19 were performed by uploading the entire protein 
coding sequence except the first 25 amino acids into the program. To generate a 3D 
model, hydrophobic values and ampiphilic values obtained from ProtoScale program 
analysis were used as per the instruction provided at the program website. 
 
Cloning and expression p28 Omp14 and p28 Omp19 gene products:  
The protein coding sequences of the p28 Omp14 and p28 Omp19 were 
amplified from E. chaffeensis genomic DNA and cloned into pET 28 expression 
plasmid vector (Novgen, Gibbstown,NJ). Nco I and Xho I sites of were engineered 
into the PCR products to aid in the directional cloning into the pET 28 plasmid. The 
coding sequences excluded the first 25 amino acids, as they were considered as the 
signal sequences. Standard molecular cloning protocols were followed for preparing 
the recombinant plasmid constructs. Briefly, the PCR products and pET 28 plasmid 
were digested with Nco1 and Xho1 and the DNAs were purified by 
phenol/chloroform and ethanol purification precipitation method. The PCR products 
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and the linerzed plasmids were ligated (5 to 1 ratio) using T4 DNA ligase. The 
ligated products were then transformed into E. coli XL1blue and plated on agar plate 
containing kanamycin. Colonies were randomly picked and grown in LB media 
(Kanamycin resistance is conferred for the pET 28 plasmid). The presence of inserts 
in a recombinant plasmid was verified after preparing plasmid DNA from 3 ml liquid 
culture and the performing restriction enzyme digestion with Nco1 and Xho1. 
Plasmids containing ~0.9 kb inserts were identified following resolving the digested 
DNA on a 1% agarose gel. The integrity of sequence a recombinant plasmid was 
confirmed by performing DNA sequence analysis of the plasmid DNAs. The 
plasmids containing desired gene segments were retransformed into E. coli strain 
BL21 (DE3). Transformed BL21 (DE3) strain cultures were assessed for the 
presence of recombinant proteins. For this experiment, Culture was grown in  10 ml 
LB medium with kanamycin (10µg/ml final concentration) and when the culture 
reached to an optimum density of ~ 0.6 at 600, protein expression was induced with 
1mM IPTG. The expression of the recombinant proteins was confirmed after 
analyzing cell lysates prepared from the cultures The 10 ml liquid culture were 
centrifuged for 5 min at 4000 rpm (Ependroff centrifugal 5810R). The supernatant 
was discarded and the bacterial pellet, I ml of lysis buffer ( 50 mM Tris-HCl, 5 Mm 
EDTA, 100 Mm NaCl, 0.5% Triton 100-X) containing lysozyme (2 µg/ml final 
concentrations) was added. The culture was resuspended by vortexing several times 
and subjected to sonication for 1 min using Sonic Dismembrator (Fisher scientific) at 
setting of 9. The cell lysates were separated to soluble and insoluble fractions by 
centrifugation at 4ºC for 5 min at 12,000 rpm (Ependroff centrifugal, 5810R). The 
presence of expressed proteins was evaluated in both the fractions, equal volumes 
of supernatant and 2x SDS gel loading buffer were mixed to prepare the protein 
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solution for analyzing on protein gel. To the insoluble fraction, 100µl of 1x SDS gel 
loading buffer was added and vortexed several times to solubilize the proteins. 
Twenty microliter each of the supernatant and insoluble fractions derived proteins 
were used to resolve on a 15 % polyacrylamide gel containing 10% SDS. The 
protocols to SDS for polyacrylamide gel electrophoresis were followed as described 
in book of Sambrook et al. The electrophoresed gel was stained with coomasie blue 
G250 staining solution and examined for the presence of proteins. The recombinant 
expressed proteins were identified in the insoluble fractions of expression constructs 
prepared for both p28-Omp14 and 19 genes. To verify the presence of specific 
products, lysates prepared from a non-recombinant plasmid transformed into E. coli 
BL21 (DE3) strain were used. Predicted 28 kDa proteins were observed in the 
insoluble fraction desired proteins of the p28-Omp 14 and 19 gene.  
Purification of recombinant proteins:  
The E. coli strains containing pET 28 recombinant plasmids were grown at 
37ºC in 10 ml of Laurie broth (LB) medium containing kanamycin (10µg/ml final 
concentration) for about 14 hours. These cultures were transferred to 1 liter of LB 
medium with kanamycin and incubated in a shaker incubator at 37ºC for expanding 
the cultures. When the cultures grown to 0.5 optical density units (measured at 600 
nm), protein expression was induced by adding 1 mM isopropyl beta D- 
thiogalactopyranoside (IPTG). The cultures were continued to grow for six hours at 
37ºC. The bacterial cultures were collected as fractions of 50 ml in Falcon tubes and 
centrifuged at 4000 rpm for 10 min (Ependroff Centrifuge, 5810 R). The culture  
pellets were pooled to four falcon tubes after resuspending in 25 ml of lysis buffer 
[500 mM Tris HCl, 100 mM NaCl, 5 mM EDTA, 0.1 mM 
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phenylmethanesulfonylfluoride (PMSF) containing of 25 µl lysozyme (20 mg/ml)] and 
then incubated at 37ºC for 30 min. The culture lysates were sonicated using Sonic 
Dismembrator (Fisher scientific) for 5 min at setting 9. The lysate was centrifuged at 
4000 rpm for 10 min to separate the insoluble and soluble fractions. To the pellet 
containing the insoluble fraction were dissolved in 25 ml of lysis buffer and vortexed 
to mix the insoluble fraction. The mixture was then centrifuged from 10 min at 4000 
rpm as described above and the supernatant was discarded. This step was repeated 
one more time to recover clean insoluble fractions that contained inclusion bodies 
with recombinant proteins. The final recovered inclusion bodies were solubilized in 
20 ml of denature  buffer [20 mM Tris-HCl buffer (pH 8.5) containing 8 M urea] and 
placed in a 65ºC water bath for 30 min to dissolve the pellet (votexing for every 10 
min, If needed). After 30 min, the dissolved solution was centrifuged at 36,000 rpm 
for 90 min (Beckman ultracentrifuge- optima max high capacity, SW 50.1) to remove 
any non-soluble proteins or macromolecules. Clean supernatant containing 
solubilized proteins was transformed to a sterile 50 ml Falcon tube and stored at -20 
ºC for further use. The presence of recombinant protein in this fraction was 
evaluated by subjecting 25 µl each of the fractions in a 15% SDS –polyacrylamide 
gel and stained in coomassie blue staining. After verifying the presence of 
recombinant proteins, the solutions were used to purify using ion exchange and size 
exclusion chromatography methods to prepare purified recombinant proteins. 
Ion exchange and size exclusion chromatography:  
Anion exchange chromatography was used for the initial steps of purification 
for p28-Omp14 and p28-Omp19 recombinant proteins. The size of the anion 
exchange column used for purification is 2.5 cm x 10 cm (Bio-Rad, Hercules, CA). 
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The column was packed up to 8 cm height of the column with anion-exchange beads 
(Q Sepharose Fast Flow, Amersham Pharmacia Biotech, Piscataway, NJ) and was 
equilibrated with 100 ml of 20 mM Tris HCl (pH 8.5) containing 8 M urea (denature 
buffer). Subsequently, the solution containing a recombinant protein was loaded on 
to the column and washed with another 100 ml of denature buffer. Bound proteins 
were eluted with a linear gradient of 0 to 1 M NaCl (200 ml volume) prepared in 
denature buffer. Total 100 fractions (2 ml each) were collected. The presence of 
protein in fractions was assessed at 280 nm by using U.V. spectrophotometer. 
Based on the values obtained from the U.V spectrophotometer, graph was plotted 
with fractions on X-axis and optical density values on Y-axis.  Fractions containing 
the major protein peak(s) were further analyzed to identify the presence of 
recombinant proteins. Twenty-five microliter each of the fractions were resolved in a 
15% SDS polyacrylamide gel and stained by following silver staining protocol. The 
fractions having the desired protein (~28 kDa) at the highest concentration were 
pooled (Figure: 2.10 for p28-Omp14 and Figure: 2.11 for p28-Omp19).  
Size exclusion chromatography:  
The ion exchange column purified pooled proteins representing ~ 28 kDa size 
proteins were concentrated to 1 ml by using Amicon ultra centrifugal filters (10,000 
Da capacity, Millipore). Proteins solutions were transferred to the filtration unit and 
centrifuged at 4,500 rpm for 40 min in Ependroff Centrifuge, 5810 R. The 
concentrated p28 protein solutions were subjected to size exclusion 
chromatography. The size of the column used for this analysis is 1 cm x 170 cm 
(Bio-rad). It was packed with Superdex beads (Superdex TM Prep grade, Amersham 
Pharmacia Biotech, Piscataway, NJ) to fill the column bed up to 150 cm height 
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(approximately 200 ml of Superdex beads were used). The column was saturated 
with 20 mM Tris HCl (pH 8.5) containing 8 M urea (denature buffer) by washing with 
about 200 ml buffer. Subsequently, concentrated protein solution of p28-Omp 14 or 
19 was loaded on to the column and eluted with 200 ml of denature buffer. Flow was 
adjusted to 1 ml per 5 min. Total 200 fractions (1 ml per fractions) were collected 
and analyzed using U.V spectrophotometer set at 280 nm to identify the presence of 
a protein. Graph was plotted with optical density on X- axis and fractions collected 
on Y-axis. Proteins fractions containing the highest absorption at 280 nm were 
collected and the presence of p28 proteins was identified by performing PAGE in 
presence of SDS (Outlined were mentioned above). The fractions containing 28 kDa 
proteins were pooled and concentrated to 1 ml solution by using Amicon ultra 
centrifugal filters as mentioned above. The protein concentration was estimated 
using the kit for RD-DC method as per the manufacturing instructions (Bio-Rad, 
Hercules, CA). The concentrated proteins were then stored at -20ºC until further use.   
 
Refolding of recombinant protein by micelle formation:  
The recombinant p28-Omp 14 or 19 proteins were concentrated further to 10 
mg in 0.3 ml volume of Tris HCl buffer (pH8.5) containing 8 M urea. The proteins 
were diluted into 20 ml of detergent solution. Typically, 20 µl each of the protein 
solution was added to the detergent solution while vortexing for using a magnetic 
stirrer at 4ºC. The slow addition of protein solution was completed in about 2.5 
hours. Three different detergents were used for the refolding of proteins. They are 
Dodecylphosphocholine (DPC), Dihexanoylphosphatidylcholine (DHPC) or β n-
Octyl-β-D-Glucopyranoside (β-OG). The detergent solutions were prepared in 20 ml 
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of 20 mM sodium borate buffer (pH 10) containg150 mM NaCl and 1 mM EDTA for 
DPC (15 mM). The DHPC (24 mM) and β-OG (24 mM) detergent solutions were 
prepared using 20 mM sodium phosphate buffer (pH 10) containing 150 mM NaCl 
and 1 mM EDTA.  
CD Spectrophotometer: The secondary structure of proteins was evaluated by 
performing CD Spectroscopy scans at wavelengths from 190–250 nm as described 
earlier [158]. CD spectroscopy analysis was performed for the detergent treated 
proteins in which proteins were imbedded to form micelles in a buffer. CD 
measurements were performed using a Jasco J-715 spectrometer (Jasco.co, 
Oklahoma City, OK). The spectra were measured in a 200 µl capacity 1 mm 
thickness cuvette with 1 cm path length using the protein solution imbedded in 
micelles (approximately 0.4 mg of protein/ml of solution). The CD measurements 
were expressed in terms of molar ellipticity. The CD data were assessed to identify 
the presence of α helices and β sheet folding structures. The protein structure was 
predicted, based on the negative minima observed in the wavelength scans. The 
minima occur at 222 nm and 210 nm is related to the presence of α helices 
structures. While bending is observed at the 218 nm is related to β sheet structure 
[158-161]. 
Liposome assay (for determining the porin activity): 
 Porin activity of the recombinant proteins was determined after reconstituting 
protein in detergents to form proteoliposomes as previously described with few 
modification [162, 163]. Typically, mixture of 2.4 picomoles of acetone-washed egg 
phosphatidylcholine (Sigma-Aldrich, St. Louis, MO) and 0.2 picomoles of 
diacetylphosphate (Sigma-Aldrich, St. Louis, MO) were dried under a stream of 
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nitrogen gas at the bottom of a test tube. Then the lipid film was resuspended in 0.2 
ml of 20 mM Tris-HCl buffer containing 2 µg of purified protein solubilized using β- 
OG. The resuspension step was completed by vortexing for about a minute and then 
by a brief sonication (1 to 2 min) in a Branson bath-type 1510 sonicator (Qsonica, 
LLC, Newtown, CT) at setting of 2.5 for 5 min. The lipid-protein mixture was then 
dried by using a vacuum desiccator ( Labconco, FreeZone Freeze Dry System, 
Labconco Corporation Kansas City, Missouri ). To make proteoliposomes, the dried 
protein-lipid film was resuspended in 0.3 ml of 10 mM Tris-HCl buffer (pH 7.5) 
containing 15% dextran T-40 (Sigma- Aldrich, St Louis,MO). Resuspension of the 
lipid film in the solution was carried out by occasional gentle rotation of the test tube, 
followed by 30 min of occasional hand shaking of the tubes. Seventeen microliters of 
proteoliposome suspensions mixed in 600 µl a solution containing solutes was used 
for proteoliposome swelling assays. Proteoliposome swelling was measured by 
recording the change in the optical density at 400 nm at various time intervals (0-500 
sec). Proteoliposome swelling, an indication of solute uptake, was monitored by the 
decrease in the optical density after proteoliposome and solutes were mixed. The 
assays were performed for the following solutions at 33 mM; glucose (MW=180), 
fructose (MW=180), sucrose (MW=342), stachyose (MW=666) and L-glutamine 
(MW=146). Assays were also repeated four different L-glutamine concentrations (10, 
20, 33, 40 mM). 
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Results  
In silco analysis:  
Hydrophobicity of the p28-Omp protein sequences was analyzed using 
ProtoScale computer program. Output from this analysis suggested that the p28-
Omp 14 and 19 proteins have 9 hydrophobic regions [Figure 9 (A) (B)]. We predicted 
that these 9 hydrophobic regions represent transmembrane domains of the proteins. 
The presence of hydrophobic domains is similar for both p28-Omp proteins. 
However, there are several differences in the peaks were observed. The 
hydrophobic domains observed for both proteins spanned between the hydrophilic 
segments and included at both N-terminal and C-terminal parts of the proteins. 
Similarities in the hydrophobicity of the p28-Omp 14 and 19 proteins may reflect 
structural similarities within these proteins. Secondary structure prediction analysis 
by PREDTMBB program supported the ProtoScale hydrophobicity data for both p28-
Omp 14 and 19 proteins. Specifically, the predicted structure by PREDTMBB 
program also identified 9 hydrophobicity segments of both p28-Omp 14 and 19 
proteins. This program further identified these segments to be part of the membrane 
bound structures [Figure 10 (A) (B)]. The hydrophilic segments were predicted as 
exposed to extracellular environment of the outer membrane. The membrane bound 
nine segments were also predicted by the program as β turn secondary structures.  
Three dimensional structure analyses of the p28-Omp 14 and 19 protein sequences 
were performed with the help of CPH model 3.0 program. The output data from this 
analysis supported the observations of hydropathy plot analysis and secondary 
structure predicted analysis by the above mentioned programs. The 3D model 
analysis showed a porin like structure with β barrel formations which included 
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hydrophobic domains of both the proteins. The β barrel structure appeared very 
similar for p28-Omp14 and 19 protein sequences. Hydrophilic domains predicted as 
exposed to the extracellular environment by PREDTMBB program were also found 
to be present in the 3D predicted models by CPH 3.0 program [Figure 11 (A)(B)]. 
The program predicted only one major extracellular loop for the p28-Omp 14 
sequence that is away from the β barrel structure, whereas two loops were predicted 
for the p28-Omp19 protein. These sequence in silco analysis suggested that the 
p28-Omp proteins may contain membrane imbedded structures with β- barrel 
structure formations. The predictions are in agreement with the previous reports 
demonstrating the presence of the proteins on the outer membrane of E. 
chaffeensis.  
Recombinant protein expression and purification:  
In support of performing more detailed investigation of p28-Omp 14 and 19 
proteins to assess the secondary structures, the protein sequences were engineered 
into an E. coli protein expression construct pET 28. The p28-Omp 14 and 19 
proteins were produced from the pET 28 recombinant plasmids in E coli strain Bl21 
(DE3). The expression of proteins was induced with IPTG. The proteins were 
expressed as inclusion bodies (judged form the presence of recombinant proteins 
found in the insoluble fraction of E. coli lysates) (Figure 12).The insoluble proteins 
from E. coli lysates were recovered by repeated washing of the collected inclusion 
bodies with lysis buffer followed by solubilizing the proteins in the denature buffer. 
Subsequent purification to obtain highly purified proteins was accomplished by using 
ion exchange and size exclusion chromatography methods. Inclusion bodies 
solubilized in denature buffer were used to absorb on to the ion exchange column 
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and subjected to elution with 0 to 1 M NaCl gradient [Figure 13 (A)(B)]. Protein 
elution was monitored for the presence of proteins in the fractions collected from 
column by U.V spectrophotometer at 280 nm. A major peak of protein was identified 
in the eluted fractions at 0.25 to 0.4 M NaCl gradient (collected from 10 fractions of 2 
ml each) for both p28-Omp 14 and 19 proteins. These fractions were further 
analyzed in a denaturing polyacrylamide gel [Figure 14 (A) (B)]. The fractions 
containing ~28 kDa proteins were concentrated from 20 ml to 1 ml and used for size 
exclusion chromatography. Size exclusion chromatography purification was 
performed to further purify the proteins. The beads of Superdex TM Prep grade 
having the resolution capacity for proteins with molecular weight ranging from 
10,000 to 60,000 kDa were used for the experiment. The concentrated protein from 
ion exchange column was added on to the size exclusion column. After the void 
volume, fractions were collected and the protein fractions were analyzed by U.V 
spectrophotometer [Figure 15 (A) (B)]. The fractions containing the p28-Omp 14 or 
19 proteins were observed in fractions 22 to 32 (each fractions represents 2 ml) after 
the void volume of 30 ml. The presence of the p28-Omp proteins were further 
confirmed by denaturing polyacrylamide gel analysis. The protein fractions with the 
purified proteins were pooled and concentrated to 7 to 8 mg/ ml using Amicon 
ultracentrifugal filter. Protein fractions were assessed from various purification steps 
(Figure 16). 
Refolding of recombinant proteins in detergents:  
 The purified p28-Omp 14 and 19 recombinant proteins in 8 M urea in 20 mM 
Tris-HCl were used to assess their folding in detergents; β-octyl glycoside (β-OG), 
dodecylphosphocholine (DPC) and dihexanoylphosphatidylcholine (DHPC). The 
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detergents were used to prepare micelles in which proteins were imbedded. Initial 
experiments were performed for p28-Omp 19 with varying concentrations of 
detergents and with a fixed concentration of 5 mg of the protein. Folding in β-OG 
was unsuccessful as the proteins were precipitated in it. Thus, the β-OG was 
rejected for subsequent analysis. To identify the concentration of detergents for the 
maximum refolding of proteins, we used varying concentrations of DPC (10, 12, 15, 
and 18 mM) and DHPC (22, 24, and 26 mM). The proteins folded in DPC and DHPC 
micelles were analyzed on a polyacrylamide gel in the presence of SDS. The 
analysis included proteins that were not treated with detergents (negative control). 
The p28-Omp 19 protein in all four concentrations of DPC had a protein band that 
migrated faster as compared to the control proteins (Figure 17). The relative 
abundance of the fast migrated protein band was the highest in 15 mM DPC. 
Similarly, DHPC treated protein also had the fast migrating protein band (Figure 18). 
This experiment was repeated for both p28-Omp 14 and 19 proteins using a fixed 
concentration of 15 mM DPC and 24 mM DHPC. The presence of folded proteins 
was also assessed by denaturing polyacrylamide gel. The p28 Omp 14 or 19 
proteins in DPC and DHPC are considered folded if fast migrating protein band are 
detected. This analysis included controls where proteins were resolved in the 
absence of a detergent. In addition, detergent treated proteins after denatured by 
boiling were also assessed. The p28-Omp14 and 19 proteins in DPC and DHPC had 
the major fast migrating proteins bands (Figure 19 and 20). The fast migrating 
protein bands were not observed in the samples that lacked detergents or boiled 
samples after detergent treatment. 
The secondary structures of the detergent treated p28-Omp proteins were 
evaluated by circular dichroism (CD) analysis. The CD scanning analysis was 
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performed at near ultra violet wavelength (190 to 280 nm) to differentiate proteins 
containing β sheet structures or α helices. β-sheet structures exhibit characteristic 
negative bend in the wavelength scan that peaks at 218 nm and this depression 
should be more pronounced for the proteins in the presence micelles compared to 
protein in buffer. If proteins contain α-helices structures, the wavelength scans show 
two negative peaks; one each at 208 nm and 220 nm. We performed CD spectra 
analysis for the recombinant p28-Omp 14 or 19 proteins [Figure 21 (A) (B)]. The 
analysis were performed for proteins in presence of 15 Mm DPC or 24 mM DHPC. 
Controls for this experiment included CD analysis performed for proteins in the 
absence of a detergent. Similarly, buffer scan also recorded to scan as non specific 
control. The CD analysis revealed the characteristic negative peaks at 218 nm for 
both p28-Omp14 and 19 proteins as expected for proteins having β-sheet structures.  
CD scans for buffer alone exhibited straight lines for the entire wavelength scans. 
The CD spectrum for the proteins in borate buffer alone also had the characteristic 
bend at 218 nm. The peaks however, were greater for the proteins in DPC and 
DHPC. 
Liposome swelling assay: 
 A recent study based on the bioinformatics analysis, suggested that E. 
chaffeensis p28-Omp19 and Omp 1F (p28-Omp 18) (another protein made from the 
p28-Omp multigene locus) have overall folded structures similar to the porin proteins 
of Gram-negative bacteria [166]. The authors in this study performed porin assays 
for the proteins and demonstrated that possess the porin activity [151]. To do similar 
analysis, proteoliposome were prepared with p28-Omp 14 and 19 recombinant 
proteins using egg-phosphotidyacholine and dicetylephostphate  [163]. The 
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proteoliposomes were then assessed for the porin activity by allowing the solutes of 
glucose (MW: 180 Da), fructose (MW: 180 Da), sucrose (MW: 342 Da), stachyose 
(MW: 666 Da) or L-glutamine (MW: 146.5 Da). Generally, proteoliposomes respond 
to a solute and swell if it passes through it. We have selected four different size 
sugars to make isosmotic solution and to assess if the proteoliposomes can permit 
the sugars to transfer. We also selected L-glutamine for proteoliposome swelling 
assay similar to studies reported by Kumagai and Rikihisa [151].  In the present 
study, L-glutamine selected because it is considered as important amino acid to be 
important from a host cell by E. chaffeensis.  
Control for this experiment included swelling assays performed for 
proteoliposome with buffer alone. Similarly, swelling assays were performed with 
liposome prepared without the addition of recombinant proteins. In this control, we 
only used buffer alone on buffer containing 33 mM L-glutamine.  No swelling was 
observed for the liposome as judged from the flat line on a time scale analysis (not 
shown). The swelling for the proteoliposome as assessed by rapid decrease in 
absorbance at 400 nm is the greatest for water. The swelling of proteoliposome was 
also observed for 33 mM glucose, fructose, sucrose, and stachyose. In this 
experiment, we also performed the porin activity as judged by the decreased 
absorbance for L -glutamine Three independent proteoliposome assays were 
performed with both p28-Omp14 or 19 recombinant proteins [Figure 22 and 23 (A, B, 
C)]. Although in all three experiments, we observed swelling in presence of sugars 
or L-glutamine. There appear to be experimental variation in the proteoliposome 
swelling. To estimate the impact of the size of the molecules, we performed size 
versus rate of swelling analysis from three independent experiments (Table 31). The 
analysis revealed no difference in the swelling of proteoliposome in presence of p28-
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Omp 14 and 19 proteins. Secondly, the proteoliposome swelling is greater for 
smaller molecule and it decreased with increasing size of sugars used in the 
analysis. 
The porin activity was also performed with four different concentration of L-glutamine 
with p28-Omp 19. The porin activity was the highest for 10 mM and it descends with 
the increase in the concentration of L-glutamine to 20, 33 mM and 40 mM. 
Discussion  
           E. chaffeensis is a relatively recently discovered pathogen transmitted from 
infected ticks to vertebrate hosts, including humans [49, 61]. Much of the research on 
this pathogen has been focused on understanding how the organism is able to 
persist in ticks and vertebrate hosts. Recent studies suggest that the pathogen 
expresses numerous proteins in a host cell specific manner [137, 141, 143]. Tick cell 
derived E. chaffeensis persists longer time in the murine host compared to bacteria 
originating from vertebrate macrophages [128]. These results suggest that the 
difference in protein expression is an important contributor for E. chaffeensis 
adaptation to vertebrate host. However, little is known about the functional 
significance of differentially expressed proteins to the pathogen’s growth. 
In this study, we focused to characterize two differentially expressed proteins 
of E. chaffeensis to define their secondary structure and to map their biological 
activities. In particular, we studied two proteins that are differentially expressed on 
the outer membrane of E. chaffeensis; they are p28-Omp14 and p28-Omp 19. The 
p28-Omp 14 is primarily expressed by the organism in tick cells both under in vitro 
and in vivo, whereas p28-Omp 19 is the major expressed outer membrane protein of 
E. chaffeensis in infected cultured macrophages and infected vertebrate hosts [112, 
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141]. These proteins gained considerable importance because they are highly 
immunogenic and are recognized by the immune sera of infected vertebrates [133, 
134, 142]. Moreover, these proteins are made from the multigene locus which 
includes 22 tandemly arranged paralogous genes [113, 139, 140, 146]. Their 
homologs are also found in other Ehrlichia species with differential expression 
reported [104, 105].  Despite their differential expression on the pathogens cell 
surface and their extensive shared homology in the primary protein structure of 
different paralogs, biological function of these proteins is not yet defined. Recent 
studies for two of these proteins p28-Omp 18 and p28-Omp 19, suggest that they 
are porin like proteins [151]. 
        To define the function of the differentially expressed p28-Omp proteins, we first 
performed in silco analysis.  The analysis supported earlier data that the p28-Omp 
14 and 19 are membrane bound proteins. We utilized three different programs to 
predict the secondary and 3D structures of these proteins. The hydrophobicity 
analysis by ProtoScale program suggested the presence of 9 hydrophobic segments 
in both the proteins [Figure 9 (A) (B)]. The PREDTMBB program confirmed these 
predictions. The prediction analysis PREDTMBB program further suggested that the 
9 hydrophobic domains are parts of the outer membrane protein embedded in the 
lipid bilayer [Figure 10 (A) (B)]. The hydrophilic domains identified by ProtoScale 
program are also predicted as the hydrophilic domains by PREDTMBB program and 
suggested that the hydrophilic segments are part of the protein exposed to 
extracellular environment. The prediction analyses data for p28-Omp 14 and 19 are 
very similar to the previous predictions made for p28-Omp 19 and 18 by kumugai 
and Rikihisa [151]. 
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The 3D modeling analysis by CPH model 3.0 are also useful in predicting the 
structure of the membrane proteins [154, 157]. Analysis of p28-Omp 14 and 19 using 
this program also supported the predictions made by ProtoScale and PREDTMBB 
programs. The 3D structure prediction analysis suggested that the proteins fold very 
similar in a lipid bilayer with β- barrel like structures formed with several β helices. 
The β helices represent protein segments with higher hydrophobicity (Figure: 11 (A) 
(B). The 3D structure predictions did not reveal obvious differences between p28-
Omp 14 and 19. The only notable difference is the presence of two extracellular 
loops; the loops appear to fold differently for these proteins.  
In support of mapping the secondary structures and differences within, we 
prepared recombinant protein of p28-Omp 14 and 19  in E. coli and purified then to 
homogeneity by employing purification techniques including differential 
centrifugation, ion-exchange and size exclusion chromatography methods. The 
methods aided in the recovery of large quantities of highly pure recombinant proteins 
of p28-Omp 14 and 19. As these are membrane proteins, they remained insoluble in 
aqueous solutions and required 8 M urea for solubilization. The function of these 
proteins cannot be assessed in non-native insoluble form. Thus, it is important to 
reconstitute the proteins to mimic the native structure imbedded in the bacterial outer 
membrane. Solubilization of membrane proteins in detergents with molecular 
weights similar to those found in the lipid bilayers of the bacterial membrane is 
technique commonly utilized [160, 164, 167]. In this study, we selected three different 
detergents β-OG, DPC and DHPC for performing solubilization studies. Experiments 
were performed to fold the p28-Omp 14 and 19 in these detergents by following the 
protocols described earlier [160, 167]. The proteins in β-OG were insoluble at the 
concentration used (20 mM) and therefore this detergent was not used for 
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subsequent experiments. Following the solubilization in DPC or DHPC, the presence 
of folded proteins was assessed by SDS PAGE analysis. Folded proteins migrate 
faster in the gel compared to non-folded proteins and therefore this method is useful 
in identifying the presence and abundance of folded proteins. Folded proteins for 
p28-Omp14 and 19 proteins are clearly visible in the polyacrylamide gel as judged 
by rapid migration of protein bands compared to proteins in the absence of DPC and 
DHPC. The folding is high at 15 mM DPC and 24 mM DHPC. These concentrations 
of DPC and DHPC are considered critical concentration of detergents required for 
forming micelles [168]. The micelles folded proteins were assessed further by 
performing CD analysis to examine the nature of the secondary structures in the 
folded proteins. The CD analysis suggested a characteristic bend at 218 nm, which 
is an indication of the presence of rich β sheet structures that are typically present in 
membrane bond proteins of Gram-negative bacteria [159, 169]. Both DPC and DHPC 
treated proteins show a negative peak at 218 nm. These results indicating the 
presence of large amounts of β sheet structures. Hydrophobic domains of a 
membrane proteins form β sheet structures and get integrated into the lipid bilayers. 
The hydrophobic domains of the proteins are imbedded within the membrane 
surface of a lipid bilayer, thus, allowing membrane proteins to interact with their 
hydrophobic environments. Previous studies on two p28-Omp proteins of E. 
chaffeensis  [p28-Omp 19 and p28-Omp 1F(Omp18)] suggest that the proteins form 
porin like structure and possibly serve as porins to allow metabolite exchange 
between the host and pathogen [151]. In this study, we assessed the proteoliposome 
as a measure for porin activity swelling for both p28-Omp 14 and 19 recombinant 
proteins after reconstituting the proteins to form in a proteoliposomes. The analysis 
suggested that the p28-Omp 14 and 19 possess the porin activity. Proteoliposome 
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assays of p28-Omp 14 and 19 proteins had shown the permeability for L-glutamine 
and for four sugars; glucose, fructose, sucrose, and stachyose. The swelling of 
proteoliposome appeared to be dependent on the size of a molecule and the 
concentration of solutes. Three independent proteoliposome assays suggested the 
highest permeability for L- glutamine fallowed by fructose, glucose, sucrose, and 
stachyose. The proteoliposome assay performed with p28-Omp 19 and L-glutamine 
suggested that the porin activity is concentration dependent and increasing 
concentration cause decrease in porin activity. 
The availability of the recombinant proteins in pure form is valuable to further 
the critical structural differences in these highly homogenous proteins and to define 
the significance of differences in the primary structure to functional variations. The 
functional differences may be understood by more structural analysis performed by 
such as by performing X-ray crystallography and nuclear magnetic resonance 
studies. 
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Figures related to Chapter 2 
 
 
 
 
 
    
Figure: 9 (A) (B) Calculating Hydrophobicity of p28-Omp14 and p28-Omp19 by 
PROTOSCALE program (Kyte and Doolittle)   
 
 
 
 
 
 
 
 
 
 
Figure: 9 (A)                                                                      Figure: 9 (B) 
Calculating Hydrophobicity 
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                                                                     Figure: 10 (B) 
Figure: 10 (A) (B): Predication of 2D model for p28-Omp14 and p28-Omp19 in 
transmembrane using PRED-TMBB program 
 
 
 
 
 
 
 
 
 
2D structural prediction by PRED-TMBB Program 
Figure: 10 (A) 
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Figure 11 (B): Predicated 3D model of p28-Omp 14 and p28-Omp 19 by using CPH 
model 3.0. 
 
 
 
 
 
 
 
 
 
3D model prediction by CPH MODEL 3.0 
52 
 
 
SDS PAGE analysis for recombinant expressed protein 
 
      1                      2                         3                          4                  5                    6 
 
 
Figure 12:   SDS-PAGE analysis of p28-Omp 14 and 19: The proteins were 
expressed in recombinant E. coli Bl21 bacterial strain.  SDS- PAGE analyses were 
performed for verifying the presence of desired protein. 1: Supernatant of p28 Omp 
14 after cell lysis, lane 2nd: Pellet of p28-Omp 14 cell lyste dissolved in 8 M urea, 
lane 3rd: Supernatant of p28 Omp 19 after cell lysis, lane 4th: Pellet of p28-Omp 19 
cell lyste dissolved in 8 M urea Cell lysates. Whereas 5 and 6th lanes are bacterial 
culture without desired recombinant plasmid. Proteins were analyzed on a 15% 
acrylamide gel and visualized by Coomasie staining. 
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 Ion exchange Chromatography analysis of recombinant gene 14 and 19 protein expressed 
elution. 
 
 
Figure 13 (A) 
 
 
Figure 13 (B) 
Figure 13 (A) (B): p28-Omp 14 and 19 protein fraction samples eluted from 
Ion exchange was analyzed by U.V spectrophometer.  
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Fractions from p28-Omp 14 ion exchange chromatography  
 
      
                      
  Figure 14 (A) 
 
Fractions from p28-Omp 19 ion exchange chromatography  
 
              
Figure 14 (B) : Ion exchanged Purified p28-Omp 14 and 19 analysis on 
SDS-Polyacrylamide gel: Maximum homogeneity protein fractions were collected 
(range from 25 to 35 fractions of p28-Omp 14 and 26 to 33 fractions for p28-Omp 
19, around 0.4 to 0.5 M NaCL gradients) were analyzed on SDS PAGE. Proteins 
were separated on a 15% acrylamide gel and visualized by Silver staining method. 
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Size exclusion chromatography  
 
Figure 15 (A): Purification p28-Omp 14 by size exclusion chrmotography 
 
Figure 15 (B): Purification p28-Omp 19 by size exclusion 
chromotography 
Figure 15 (A) (B):  Elution profile obtained from the size-exclusion 
chromatography step using the 1*175 cm column containing Superdex beads75 
(26/60) column. Flow rate at 1 mL/min with 20 mM Tris HCl buffer (pH 7.5) and 100 
mM NaCl. Eluted fractions were collected after void volume of 20 ml (Ranges from 
25 to 35) for p28-Omp 14 and p28-Omp 19. 
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Protein fraction assessed from various purification steps  
           1               2                  3                 4  
 
        5                 6                  7                 8  
 
Figure 16:  Protein sample from each Purification step was anyalsed by SDS-
Polyacrylamide gel. 
 p28-Omp 14: lane1: cell lystes, lane 2: Centrifugation separated, lane 3rd: 
Ion exchange purified and 4th  lane: Size exclusion chromatography purified  
p28 – Omp 19: Lane 5th: cell lystes, lane 6th: Centrifugation separated 
sample, lane 7th:Ion exchange purified sample , lane 8th : Size exclusion 
chromatography purified sample 
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Detergent treatment  
Various concentration of DPC micelle treatment with p28-Omp19 
 
                    
  
Figure 17: p28 Omp 19 was folded in 10 mM,  12mM, 15 mM and 19 mM.  all 
solution were buffered with 20 mM sodium phosphate buffer, pH  8.0 at 4⁰C  for 
overnight. Protein was visualized by staining with coomasie blue. C is control; 
protein without detergent treatment. 
  Various concentration of DHPC micelle was used p28-Omp19 refolding. 
 
                            
 Figure 18: p28-Omp 19 was treated with in 22 mM, 24 mM, and 26 mM of 
DHPC.  All solution were buffered with 20 mM sodium phosphate buffer, pH 8.0 at 
4⁰C for overnight. Protein was visualized by staining with coomasie blue. C is a 
control: protein without detergent treatment. 15% SDS PAGE were used for 
analyzing. 
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58 
 
 
 
 
 
 
p28-Omp 14 and 19 treated with DPC detergent and analyzed by  15% SDS 
Page gel  
 
                      
 Figure 19: Both p28-Omp 14 and 19 were treated with 15 mM DPC at 4⁰C 
for overnight. Lane 1: Marker lane 2nd: p28-Omp 14 treated with detergent, lane 3 :( 
Control) untreated p28-Omp 14. lane 4th: p28-Omp 19 treated with detergent, lanes 
5th : untreated p28-Omp 19, lane 6th and 7th were heat modifiability of DPC detergent 
treated p28 Omp14 and 19 All solution were buffered with 20 mM sodium phosphate 
buffer, pH 8.0 . Proteins were visualized by coomasie staining. 
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p28-Omp 14 and 19 treated with DHPC detergent and analyzed  by  15% SDS 
Page gel  
     
                            
 
 Figure 20: Analysis of DHPC detergent folded protein: Both p28-Omp 14 
and 19 were treated with 24 mM DHPC at 4⁰C for overnight. Lane 1: Marker lane 
2nd: p28-Omp 14 treated with detergent, lane 3rd: Heat modifiability of DHPC 
detergent treated p28-Omp 14, lane 4th: p28-Omp 19 treated with detergent, lanes 
5th : Heat modifiability of DHPC detergent treated p28-Omp 19, lane 6th and 7th were 
untreated p28 Omp14 and 19 proteins. All solution were buffered with 20 mM 
sodium borate buffer, pH 8.0 . Proteins were visualized by coomasie staining. 
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   Figure 21 (A):  Comparison between water soluble and detergent folded of 
p28-Omp 14.  DPC detergent in Sodium borate buffer and DHPC detergent in 
Sodium phosphate buffer at pH8.0 used for refolding.  
CD SPECTRA of (-) Buffer, (   ) Water, (--) Buffer/Detergent, (   ) p28-Omp 
14/DPC detergent, (    ) p28-Omp 14/DHPC detergent,(O) p28-Omp 14W/o micelles. 
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Circular Dichroism analysis of p28-Omp 19 treated with DPC and DHPC 
detergent 
 
     Figure 21 (B): Comparison between water soluble and detergent folded of p28-
Omp 19.  DPC detergent in Sodium borate buffer and DHPC detergent in Sodium 
phosphate buffer at pH8.0 used for refolding. 
CD SPECTRA of (    ) buffer, (-) water, (--) Buffer/Detergent, (  ) p28-Omp 19/DPC 
micelles, (   ) p28-Omp 19/DHPC micelles, (O) p28-Omp 19W/o micelles  
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Figure: 22 (A) (B) (C) Proteoliposome assay p28-Omp 14 
Figure 22(A) 
Figure 22(B) 
Figure 22(C) 
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Figure 22 (A) (B) (C): Porin activity of the E. chaffeensis outer membrane 
p28-Omp 14(recombinant). The diffusion rates of solutes into proteoliposome 
reconstituted with E. chaffeensis outer membrane proteins were monitored as the 
decrease in OD400.  When proteoliposome were diluted in isosmotic solution of 33 
mM Glucose (-) (MW=180), 33 mM sucrose (-) (MW=342), 33 mM fructose (-) 
(MW=180), 33 mM, L- glutamine (-) (MW=156) and 33Mm stachyose (-) (MW=666).  
(Three independent experiments are shown performed on (A) 12/24/2010, (B) 
1/13/2011, (C) 1/20/2011). 
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Figure: 23 (A) (B) (C) Proteoliposome assay p28-Omp 19 
Figure 23(A) 
Figure 23 (B) 
Figure 23(C) 
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Figure 23 (A) (B) (C): Porin activity of the E. chaffeensis outer membrane p28-Omp 
19(recombinant). The diffusion rates of solutes into proteoliposome reconstituted 
with E. chaffeensis outer membrane proteins were monitored as the decrease in OD 
400.  When proteoliposome were diluted in isosmotic solution of 33 mM Glucose (-) 
(MW=180), 33 mM sucrose (-) (MW=342), 33 mM fructose (-) (MW=180), 33 mM, L- 
glutamine (-) (MW=156) and 33Mm stachyose (-) (MW=666).  (Three independent 
experiments are shown performed on (A) 12/24/2010, (B) 1/13/2011, (C) 1/20/2011). 
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Rate of proteoliposome swelling assay (Average of independent experiment)  
 
Table: 2: Proteoliposome assay: Based on decrease in OD position, number is 
allotted and graph is represented. (Average of three independent experiment was 
taken)  
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Proteoliposome assay (p28-Omp 19) with four different concentration of L-
glutamine 
 
Figure 24: Porin activity of the E. chaffeensis outer membrane p28-Omp 
19(recombinant) with L- glutamine.  
The diffusion rates of solutes into proteoliposome reconstituted with E. 
chaffeensis outer membrane proteins were monitored as the decrease in OD400. 
When p28-Omp 19 proteoliposome were diluted in isosmotic solution of 10 mM L-
glutamine (-),  20 mM L-glutamine (-), 33 mM L-glutamine (-), 45 mM L-glutamine (-). 
For control, water with proteoliposome (-) and water with liposome (-) were taken. 
The representative results of more than three independent experiments are shown. 
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         Protocols for molecular biology techniques  
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Polymerase chain reaction (PCR): All PCR‘s were performed in final reaction 
volume of 25 μl. Each reaction contains a final concentration of 1X PCR reaction 
buffer, 50 nmoles of MgCl2, 10 nmoles of dNTP's, 10 pico moles each of forward 
and reverse primers, about 1ng of template DNA, and 1 unit of taq DNA polymerase 
(Invitrogen technologies, Carlsbad, CA). For PCR reactions that require proof 
reading, the PCR conditions are; 1x Pfx amplification buffer, 1 U of platinum Pfx 
DNA polymerase (Invitrogen Technologies, Carlsbad, CA), 5 nmoles of dNTP's, and 
rest of the reagents concentrations are maintained same as in above described 
reaction. The PCR temperature cycles include an initial heating to 95°C for 2 min, 
followed by 40 cycles of 95°C denaturation for 30 sec, primer annealing for 30 sec 
and carried out at appropriate temperatures calculated for each primer set, 72 °C 
extension for 30 sec. The extension temperature for platinum Pfx DNA polymerase 
is 68 °C. The extension temperatures were increased to 1min per each kb of 
expected amplicons length. Each reaction set included a negative control, which 
lacked a template but contained all the other reaction components. After reaction is 
complete the products were resolved on agarose gels containing ethidium bromide 
and visualized under UV light.  
Restriction enzyme digestions: Typically restriction enzyme digestion reaction is 
performed in a 20 μl volume. The reaction included 1x restriction enzyme reaction 
buffer, 1 μg of DNA, 1-5 units of enzyme, 0.5 μl of BSA (10 μg/ μl), and water to a 
final volume of 20 μl. Typically the restriction enzyme digestion is carried out at 37°C 
for 2 h unless an enzyme requires a specific temperature. For all the reactions that 
utilized two restriction enzymes, a buffer optimal for both the enzymes is utilized.  
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Phenol purification of DNA: DNA fragments from PCR, restriction enzyme 
digestion, and filling-in reactions are purified phenol purification method. Typically, 3 
M sodium acetate is added to final concentration of 0.3 M into a microcentrifuge tube 
containing DNA and final volume was adjusted to 200 μl with TE buffer. Two 
hundred micro liters of phenol (pH, 8.0) is added, vertexed to mix and centrifuged at 
15,000 g for 15 min at 4°C. The top aqueous layer is transferred into a clean 
microcentrifuge tube and added a 200 μl of phenol:chloroform:isoamylalcohol 
(25:24:1) mixture. The contents are mixed by vortexing and centrifuged at 4°C at 
15,000 g for 15 min. The top layer is transferred into another clean microcentrifuge 
tube. Thease steps were repeated with pheol:chloroform:isoamylalacohol and then 
with chloroform:isoamylalacohol. To the final removed aqueous layer, 0.5 ml 
absolute cold ethanol is added, incubated at -20°C for 15 min followed by 
centrifugation at 15,000g for 15 min. The DNA pellet is washed with 0.5 ml of 70% 
ethanol. Final pellet was air dried, resuspended in 20 μl TE buffer and stored at -20 
°C until use. 
Ligation reactions: A typical ligation reaction included approximately 25 ng of 
linearized purified plasmid vector DNA, 5 to10 molar excess of insert DNA, 1x 
ligation buffer, 5 units of T4 DNA ligase (Promega Corporation, Madison, WI) in a 20 
μl reaction volume. The ligation reaction is carried out by incubating the contents at 
15°C for 16 h. Following the ligation, 1 μl of ligation mix is used for transformation by 
chemical method. Alternatively, for use in transformation by electroporation method, 
the DNA is purified by phenol:choloform:isoamyl alcohol method described above. 
Preparation of E. coli cells for use in chemical transformation methods: The E. 
coli strains utilized to prepare competent cells included Top 10 cells (Invitrogen 
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Technologies, Carlsbad, CA), DH5α (Stratagene, La Jolla, CA), and BL21 (DE3) 
(Novagen Inc., Madison, WI). Top 10 stain of E. coli is always grown in the presence 
of streptomycin (35μg/ml). DH5α and BL21 (DE3) stains are grown in a plain LB 
medium. To prepare chemical competent cells, an E. coli colony of a desired strain 
is cultured in 3 ml of LB medium overnight in a 37°C incubator, shaking at 250 rpm. 
Subsequently, E. coli culture is re-inoculated into 100ml LB medium and grown in a 
37°C incubator. After the cells are grown to 0.4 OD (measured at 600nm), the 
cultures are harvested by centrifuging at 2,500 g for 5 min at 4°C. The cell pellet is 
resuspended in 10 ml of freshly prepared 10 mM Tris-HCl (pH, 7.5) and 50 mM 
CaCl2, and incubated on ice for 30 min. The cultures was centrifuged again at 2,500 
g for 5 min at 4°C and the pellet is suspended in 2 ml of 10 mM Tris-HCl (pH, 7.5) 
and 50 mM CaCl2 and stored at 4°C. The competent cells made by this procedure 
are utilized within 24 h after their preparation. 
Transformation: Transformation of ligated products into E. coli cells is achieved 
either by a chemical method or through an electroporation procedure. To transform 
by chemical method, 200 μl of chemical competent E. coli cells are mixed with 50 of 
100mM CaCl2 and 49 μl of sterile water. One μl of ligation products are added to 
this suspension and mixed by gentle tapping of the tube. The contents are then 
incubated in ice for 15 min, followed by a heat shock at 42°C for 2 min. The cells are 
incubated at room temperature for 10 min, added 1 ml of LB medium, and incubated 
at 37 °C in a shaker incubator set at 200 rpm for 1h.  
 
Preparation of Luria-Bertani (LB) media: The LB liquid medium and LB agar 
plates were utilized to grow E. coli cultures. To prepare 1 lit of LB liquid medium, 15 
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g tryptone, 10 g of yeast extract and 10 g of sodium chloride were dissolved in 1 lit of 
double distilled water and pH of the solution was adjusted to 7.0 with the help of 10N 
NaOH. The LB medium was autoclaved at a liquid cycle. LB agar plates preparation 
included similar preparation as described above but 15 g of cell culture grade agar 
powder was added to the medium prior to autoclaving. After autoclaving, the LB agar 
medium was allowed to cool to nearly 60°C and a desired concentration of 
appropriate  antibiotic was added to the medium. Approximately 15 ml of medium 
was poured into sterile agar plates. After solidification of the agar medium, the plates 
were wrapped and stored at 4°C until use. 
 
Selection of recombinant clones: Two hundred micro liters of transformed 
bacterial cultures are transferred onto LB plates containing appropriate antibiotic 
specific to a recombinant plasmid. The culture is uniformly dispersed onto the agar 
plate using a bacterial culture spreader. To grow the transformed E. coli the plates 
were incubated overnight in a 37°C incubator. The presence of transformants is 
assessed by comparing plates containing appropriate controls (ligation controls, no 
transformation controls). Subsequently, several colonies are selected, inoculated in 
a culture tube containing LB medium with appropriate antibiotic and are grown 
overnight at 37 °C in a shaker incubator to isolate the plasmid DNA. 
 
Isolation of Plasmid DNA: From overnight grown E. coli cultures plasmid DNA is 
isolated by following boiling preparation method (336). To isolate plasmid DNA, 1.5 
ml of overnight grown bacterial cultures are transferred into a micro centrifuge tube 
and centrifuged 12,000 g for 5min. The supernatant was aspirated carefully with the 
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help of a vacuum device and cell pellet is resuspended in 0.4 ml plasmid lysis buffer 
(10mM Tris-HCl pH 8.0, 0.1 M NaCl, 1mM EDTA, 5% v/v Triton X-100) with the help 
of a tooth pick. Twenty five micro liters of freshly prepared lysozyme (10 mg/ml) is 
added. Lysozyme was prepared by dissolving 10mg of lysozyme powder in 1 ml of 
10 mM Tris-HCl buffer (pH, 8.0) to get a final concentration of 10 mg/ml. The 
contents of the tube are vertexed to mix, placed in a boiling water bath exactly for 40 
sec, and centrifuged at 12,000 g for 15 min at 4°C. The pellet containing cell debris 
is removed with the help of a tooth pick. Four hundred and twenty μl of 100%, cold (-
20°C), isopropanol is added to the supernatant and mixed by vertexing, incubated at 
room temperature for 5 min and centrifuged at 12,000 g for 15 min to recover 
plasmid DNA. Supernatant is discarded and the DNA pellet is washed with 70% 
ethanol and dried in a speed-vac system (Labconco Centrivap Concentrator, Kansas 
City, MO) typically for about 5 min. Final pellet is resuspended in 100 μl of TE buffer 
and contaminating bacterial RNA was removed by treating with 1 μl of RNase A (1 
mg/ml) at 37°C for 5 min. The presence and quality of the plasmid DNA was 
checked by agarose gel electrophoresis (described separately). 
 
 Isolation of genomic DNA: Genomic DNA of E. chaffeensis grown in tick or 
macrophage cultures is isolated by sodium dodecyl sulfate-proteinase K-phenol, 
chloroform-isoamyl-alcohol method (336). Briefly, 1.5 ml of E. chaffeensis cultures 
are harvested by centrifugation at 12,000 g for 15 min and the cell pellet is 
resuspended in 0.5 ml of DNA extraction buffer (10 Mm Tris-Cl pH 8.0, 0.1 M EDTA, 
and 0.5% SDS) containing 0.5 mg/ml proteinase K (Sigma Chemical Co., St. Louis, 
MO). The contents are mixed by vertexing and incubated for 2 h at 60°C. 
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Phenol:chloroform:isoamyl alcohol extraction method is used to remove 
proteinecious material and ethanol is added to concentrate DNA as described 
previously. DNA pellet is air dried and resuspended in 100 of TE buffer. To remove 
the contaminating RNA, the DNA is treated with 1 μl RNase A (10 mg/ml) at room 
temperature for 10 min. The DNA samples were stored at -20°C until use. 
Agarose gel electrophoresis: Plasmid DNA, restriction digestion products or PCR 
products are analyzed by resolving them on a 0.9% agarose gels by subjecting to 
electrophoresis. The agarose gels are prepared after dissolving agarose powder in 
1x TAE buffer (40 mM Tris-acetate, 1 mM EDTA; final pH 8.0) containing 0.1 μg/ml 
of ethidium bromide. The contents are poured on a gel holding device and are 
allowed to solidify at room temperature. The gel is placed in an electrophoresis 
chamber containing 1X TAE buffer with 0.1 μg/ml of ethidium bromide dissolved in it. 
About 5 μl of DNA is loaded into the wells. Molecular weights markers are also 
loaded in a separate well and resolved to help in determining the approximate 
molecular weight of the DNA. The DNA is subjected to electrophoresis in the 
agarose gel at 70 V for 60-90 minutes and is visualized under UV illumination. The 
images are captured using Kodak gel imaging system. 
 
Automated sequencing: Recombinant DNA clones were sequenced to verify the 
accuracy and orientation of the insert DNA using CEQ Genetic Analysis System and 
by following the manufacturer’s recommendation (Beckman & Coulter, Fullerton, 
CA). Prior to performing a sequencing reaction, the recombinant plasmid DNA is 
purified by phenol:chloroform:isoamyl alcohol (25:24:1) method as described above. 
Following the purification, the concentration of the DNA was estimated by Nanodrop 
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method. The purified plasmid DNA is sequenced using a forward or reverse primer 
(plasmid derived sequence primers) specific to a sequence upstream or downstream 
to insert DNA, respectively. Sequencing reaction is performed utilizing DTCS 
sequencing kit by following the manufacturer’s recommendations (Beckman and 
Coulter, Fullerton, CA). Sequence analysis is performed using Genetics Computer 
Group (GCG) (87) or Vector. 
Silver stain preparation: Dilute Silver Stain 10 folds (e.g. Dilute 5 ml of the stain in 
45 ml de-ionized water), then add 65:l of Sensitizer-I per 50ml diluted Silver Stain. 
Soak the gel in diluted and Sensitizer-I added Silver Stain for 20-30 min with gentle 
rocking of the gel, depending upon the thickness of the gel. 
 
Silver staining Developer preparation: 
While the gel is staining, prepare the developer. Add one heaping spoonful (3-5gm) 
of Developer to 100ml of de-ionized water. After the developer is dissolved, add 65 :l 
of Sensitizer-I and 65:l of Sensitizer-II. Rinse the gel 10-20 seconds with de-ionized 
water. Soak the gel in Developer-Sensitizer-I & II. Gently rock the gel until bands are 
visible. Band intensity will develop quickly.As soon as band intensity reaches an 
acceptable level, stop development with 2% acetic acid. Transfer the gel into 
theacetic acid solution and incubate for 10 min. Gel may be stored in 2% acetic acid 
or water. 
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